| | |
| Federal agency accepts Nevada hospital's plan to curb patient-dumping Friday, May 24, 2013 05:59 PM PDT By Ronnie Cohen (Reuters) - Federal authorities approved a Nevada hospital's proposal on Friday for correcting deficiencies that led to newly discharged psychiatric patients being bused out of state without adequate plans for continued care. The U.S. Centers for Medicare and Medicaid Services also said it would conduct unannounced inspections of Rawson-Neal Psychiatric Hospital in Las Vegas to ensure that procedures are in place and working to prevent further instances of so-called patient dumping. ... Full Story | Top |
| Exclusive: 'Workplace wellness' fails bottom line, waistlines - RAND Friday, May 24, 2013 03:37 PM PDT By Sharon Begley NEW YORK (Reuters) - A long-awaited report on workplace wellness programs, which has still not been publicly released, delivers a blow to the increasingly popular efforts, Reuters has learned, casting doubt on a pillar of the Affordable Care Act and a favorite of the business community. According to a report by researchers at the RAND Corp, programs that try to get employees to become healthier and reduce medical costs have only a modest effect. ... Full Story | Top |
| Certain chronic pain may raise suicide risk Friday, May 24, 2013 02:28 PM PDT By Andrew M. Seaman NEW YORK (Reuters Health) - Back pain, migraine and other types of chronic pain without a known physical cause - and therefore little prospect for relief - were associated with an increased risk of suicide in a new study of U.S. veterans. But the researchers, who analyzed data on about five million patients in the U.S. Department of Veterans Affairs Healthcare System, found no link between suicide and arthritis, neuropathies or non-migraine headaches. Dr. ... Full Story | Top |
| Veterans' claims put pressure on Obama even as backlog dips Friday, May 24, 2013 02:06 PM PDT | Top |
| Judge orders Philadelphia faith-healing couple held in son's death Friday, May 24, 2013 01:43 PM PDT By Dave Warner PHILADELPHIA (Reuters) - A Philadelphia couple charged with murder after their baby died without medical care must be held in jail whether or not they make bail, a judge ruled on Friday. The couple, Herbert and Catherine Schaible, believe in faith healing, and those who share their beliefs might be willing to harbor them if they decide to flee, Judge Benjamin Lerner told a court hearing in Philadelphia. The Schaibles were charged with third-degree murder on Wednesday after the April 18 death of their seven-month-old son Brandon from bacterial pneumonia, dehydration and strep. ... Full Story | Top |
| Some with defibrillators may safely play sports Friday, May 24, 2013 01:41 PM PDT By Andrew M. Seaman NEW YORK (Reuters Health) - Despite expert guidelines advising against intense sports activity for people with implanted heart defibrillators, a new study suggests that some can compete without serious consequences. Researchers followed 372 athletes with defibrillators for about two and a half years and found that none died while running, skiing or playing sports like basketball and soccer. ... Full Story | Top |
| New U.S. fears emerge over tainted compounded steroids Friday, May 24, 2013 01:26 PM PDT By Toni Clarke (Reuters) - The Food and Drug Administration said on Friday it has received seven reports of illnesses in patients who took steroid injections compounded by a pharmacy in Tennessee. The FDA said full clinical information about the patients is still being gathered, but it suggested some of the problems were infections and that "at least one of these infections appears to be fungal in nature." The steroid in question is same one - methylprednisolone acetate - that was linked to a meningitis outbreak last year that has killed some 53 people and sickened more than 700. ... Full Story | Top |
| Bausch & Lomb's Ista pleads guilty over kickbacks Friday, May 24, 2013 01:25 PM PDT By Jonathan Stempel (Reuters) - Ista Pharmaceuticals Inc pleaded guilty on Friday to charges it used kickbacks and improper marketing to boost sales of a drug meant to treat eye pain and agreed to pay $33.5 million to settle criminal and civil liability, the U.S. Department of Justice said. The unit of eye care company Bausch & Lomb pleaded guilty to conspiracy to offer kickbacks to induce physicians to prescribe Xibrom, a drug meant to treat pain after cataract surgery, and conspiracy to promote that drug for unapproved uses, including after Lasik and glaucoma surgeries. ... Full Story | Top |
| Valeant near deal to acquire Bausch & Lomb: source Friday, May 24, 2013 01:16 PM PDT By Greg Roumeliotis and Jessica Toonkel NEW YORK (Reuters) - Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch & Lomb Holdings Inc from Warburg Pincus LLC for about $9 billion, a person familiar with the matter said on Friday. Valeant shares spiked to their highest level since 2001 and were up 13 percent at C$86.86 in afternoon trading in Toronto. "This deal would not be too surprising given that Valeant has said it wants to do a big, mega deal and there are not that many candidates," said David Krempa, an analyst at Morningstar. ... Full Story | Top |
| DOJ subpoenas documents on Forest Labs' inhalation drug Friday, May 24, 2013 11:15 AM PDT (Reuters) - Drugmaker Forest Laboratories received a subpoena earlier this month from U.S. prosecutors requesting documents relating to its small-selling lung disorder product, the Tudorza Pressair inhaler, the company said in a filing. The New York-based company said it was cooperating with the request in the May 6 subpoena. It did not respond to a request for further comment. A spokeswoman for the U.S. Attorney's Office in New York also declined to comment. The subpoena, which came from the U.S. ... Full Story | Top |
| New bird flu may be capable of human to human spread - study Friday, May 24, 2013 09:09 AM PDT | Top |
| C-sections tied to child obesity Friday, May 24, 2013 09:09 AM PDT | Top |
| WHO to help Saudi Arabia investigate coronavirus before haj Friday, May 24, 2013 08:46 AM PDT | Top |
| Novo obesity drug could launch in U.S. end 2014 Friday, May 24, 2013 03:50 AM PDT COPENHAGEN (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential. The world's biggest insulin producer is hoping the treatment for severe obesity will help to at least partly offset the delay to its next generation insulin treatment Tresiba after U.S. regulators asked for more tests. ... Full Story | Top |
|

No comments:
Post a Comment